Related Experiment Videos
The relative predictive performance of two theophylline pharmacokinetic dosing programs
T J Hoon1, C A Wood, M A Whidden
1Department of Pharmacy Practice, College of Pharmacy, University of Illinois, Chicago.
Pharmacotherapy
|January 1, 1988
Summary
The Abbott program showed less bias than the Simkin program for initial theophylline dosing. Both programs improved prediction accuracy with subsequent serum theophylline concentration monitoring.
Area of Science:
- Pharmacokinetics
- Clinical Pharmacology
- Drug Dosing
Background:
- Theophylline is a critical medication requiring precise dosing.
- Accurate pharmacokinetic dosing programs are essential for therapeutic drug monitoring.
- Evaluating and comparing existing dosing algorithms is crucial for clinical practice.
Purpose of the Study:
- To compare the predictive performance of two theophylline pharmacokinetic dosing programs: Abbott and Simkin.
- To assess bias and precision in predicting theophylline serum concentrations.
Main Methods:
- Utilized data from 44 inpatients with two measured theophylline serum concentrations (TSC).
- Assessed predictive bias using median prediction error (PE).
- Assessed predictive precision using median absolute prediction error (PE).
Main Results:
- The Abbott program demonstrated significantly less bias than the Simkin program for the first TSC prediction (PEs 0.1 vs -1.3 µg/mL, p < 0.05).
- No significant differences in bias were found for the second TSC prediction.
- No significant differences in precision were observed for either TSC prediction.
- Both programs showed improved prediction precision when using the first TSC to predict the second.
Conclusions:
- The Abbott and Simkin pharmacokinetic dosing programs show potential utility in guiding theophylline therapy.
- Continuous theophylline serum concentration monitoring remains essential.
- Clinical judgment is indispensable when interpreting and applying dosing program outputs.